Delphi advisor to Signet Healthcare Partners in the investment in NorthX Biologics

Delphi has assisted Signet Healthcare Partners in connection with its investment in NorthX Biologics, a leading Nordic biopharmaceutical contract development and manufacturing organization (CDMO). The investment enables NorthX Biologics to accelerate its expansion plans, including facility enhancements and service line extensions. The investment was made through a new issue of shares.

Signet Healthcare Partners is a leading provider of growth capital to innovative healthcare companies with expertise in pharmaceutical services.

Delphi’s team consisted of David Aversten, Christoffer Malmström, Jenny Lindén, Robin Rafiee, Fredrik Nykvist, Karin Roberts, Sofie Österberg, Amanda Bos Ekman, Ida Nordmark, Olivia Svedmark, and Klara Thyrén.